Here, we show that p53 represses A3B expression and cytosine deaminase activity in cancer cells, through a p21-dependent mechanism and that loss of p53 activity through its mutation or HPV-16 E6/E7-mediated downregulation, causes A3B upregulation. The gene discussed is CDKN1A; the disease is cancer.